MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Read More…
Industry, Sector and Symbol
Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
Phone212-578-9500
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$67.94 billion
Profitability
Miscellaneous
Employees48,000
Next Earnings Date10/30/2019 (Confirmed)
OptionableOptionable
Metlife (NYSE:MET) Frequently Asked Questions
What is Metlife's stock symbol?
Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."
How often does Metlife pay dividends? What is the dividend yield for Metlife?
Metlife announced a quarterly dividend on Monday, July 8th. Investors of record on Tuesday, August 6th will be given a dividend of $0.44 per share on Friday, September 13th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.82%. The ex-dividend date of this dividend is Monday, August 5th. View Metlife's Dividend History.
How will Metlife's stock buyback program work?
Metlife declared that its Board of Directors has initiated a stock buyback plan on Thursday, November 1st 2018, which authorizes the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 4.6% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its shares are undervalued.
How were Metlife's earnings last quarter?
Metlife Inc (NYSE:MET) announced its earnings results on Wednesday, July, 31st. The financial services provider reported $1.38 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.07. The financial services provider earned $16.45 billion during the quarter, compared to the consensus estimate of $16.43 billion. Metlife had a return on equity of 9.75% and a net margin of 9.28%. The business's revenue for the quarter was down 22.4% compared to the same quarter last year. During the same period last year, the business posted $1.30 earnings per share. View Metlife's Earnings History.
When is Metlife's next earnings date?
How can I listen to Metlife's earnings call?
Metlife will be holding an earnings conference call on Wednesday, October 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What price target have analysts set for MET?
11 analysts have issued 12-month price objectives for Metlife's shares. Their predictions range from $41.00 to $57.00. On average, they anticipate Metlife's share price to reach $49.34 in the next twelve months. This suggests a possible upside of 7.0% from the stock's current price. View Analyst Price Targets for Metlife.
What is the consensus analysts' recommendation for Metlife?
11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 1 sell rating, 5 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.
What are Wall Street analysts saying about Metlife stock?
Here are some recent quotes from research analysts about Metlife stock:
- 1. According to Zacks Investment Research, "MetLife’s earnings of $1.38 per share beat the Zacks Consensus Estimate by 5.34%, and were up 6.2% year over year, on the back of lower expenses, partly offset by decline in revenues. Shares of the company have outperformed its industry, year to date. It has been performing well led by prudent underwriting and expense management. Its efforts to streamline business and focus on core operations are impressive. The company’s revenue base has been growing and the trend is likely to continue. Its disciplined capital deployment is expected to drive long-term growth. However, its exposure to cat loss remains a concern. Investment in efficiency programs will put pressure on margins. Also, the company's declining net investment income might continue to suffer in 2019 due to low investment yields." (8/2/2019)
- 2. Wells Fargo & Co analysts commented, "We do not expect much movement in the shares after our meetings. Our EPS estimates and price target are unchanged. We continue to have an Outperform rating on the shares." (6/5/2019)
Has Metlife been receiving favorable news coverage?
Media stories about MET stock have trended very negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Metlife earned a daily sentiment score of -3.8 on InfoTrie's scale. They also gave media headlines about the financial services provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Metlife.
Are investors shorting Metlife?
Metlife saw a drop in short interest during the month of September. As of September 30th, there was short interest totalling 12,460,000 shares, a drop of 12.5% from the August 30th total of 14,240,000 shares. Based on an average daily volume of 6,220,000 shares, the days-to-cover ratio is presently 2.0 days. Approximately 1.6% of the company's stock are sold short. View Metlife's Current Options Chain.
Who are some of Metlife's key competitors?
Some companies that are related to Metlife include China Life Insurance (LFC), AXA (AXAHY), Prudential Public (PUK), Manulife Financial (MFC), Prudential Financial (PRU), SWISS RE LTD/S (SSREY), Sun Life Financial (SLF), AVIVA PLC/ADR (AVVIY), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), Lincoln National (LNC), AEGON (AEG), Globe Life (GL), Reinsurance Group of America (RGA) and SONY FINL HOLDI/ADR (SNYFY).
What other stocks do shareholders of Metlife own?
Who are Metlife's key executives?
Metlife's management team includes the folowing people:
- Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)
- Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)
- Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
- Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)
- Mr. John Arthur Hall, Sr. VP & Head of Investor Relations
Who are Metlife's major shareholders?
Metlife's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Robeco Institutional Asset Management B.V. (0.18%), PGGM Investments (0.13%), Envestnet Asset Management Inc. (0.10%), Douglas Lane & Associates LLC (0.08%), Zurcher Kantonalbank Zurich Cantonalbank (0.06%) and CHURCHILL MANAGEMENT Corp (0.04%). Company insiders that own Metlife stock include Carlos M Gutierrez, Christopher G Townsend, Gerald L Hassell, John D Mccallion, Steven A Kandarian and Steven J Goulart. View Institutional Ownership Trends for Metlife.
Which institutional investors are selling Metlife stock?
MET stock was sold by a variety of institutional investors in the last quarter, including Douglas Lane & Associates LLC, Abner Herrman & Brock LLC, Gateway Investment Advisers LLC, Zurcher Kantonalbank Zurich Cantonalbank, Gofen & Glossberg LLC IL, Arden Trust Co, Oakbrook Investments LLC and CHURCHILL MANAGEMENT Corp. Company insiders that have sold Metlife company stock in the last year include John D Mccallion and Steven J Goulart. View Insider Buying and Selling for Metlife.
Which institutional investors are buying Metlife stock?
MET stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Commerzbank Aktiengesellschaft FI, Robeco Institutional Asset Management B.V., State of Alaska Department of Revenue, Envestnet Asset Management Inc., Alpha Cubed Investments LLC, Nisa Investment Advisors LLC and Iowa State Bank. Company insiders that have bought Metlife stock in the last two years include Carlos M Gutierrez and Gerald L Hassell. View Insider Buying and Selling for Metlife.
How do I buy shares of Metlife?
Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Metlife's stock price today?
One share of MET stock can currently be purchased for approximately $46.10.
How big of a company is Metlife?
Metlife has a market capitalization of $43.17 billion and generates $67.94 billion in revenue each year. The financial services provider earns $5.12 billion in net income (profit) each year or $5.39 on an earnings per share basis. Metlife employs 48,000 workers across the globe.View Additional Information About Metlife.
What is Metlife's official website?
How can I contact Metlife?
Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.
MarketBeat Community Rating for Metlife (NYSE MET)
MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.
